Dynamic Technology Lab Private LTD Glycomimetics Inc Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.07 - $5.0 $34,430 - $56,075	-11,215 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.06 - $3.76 $23,102 - $42,168	11,215 New	11,215 $42,000
Q1 2020 May 13, 2020	SELL	$1.83 - $5.41 $21,718 - $64,205	-11,868 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.03 - $6.5 $47,828 - $77,142	11,868 New	11,868 $63,000
Q4 2017 Feb 09, 2018	SELL	$10.51 - $17.22 $199,416 - $326,732	-18,974 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$10.14 - $14.85 $58,477 - $85,639	5,767 Added 43.67%	18,974 $265,000
Q2 2017 Aug 17, 2017	BUY	N/A	13,207	13,207 $146,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.